Logo Logo Logo Logo Logo
  • COMPANY
    • ABOUT US
    • Management team
    • Board of Directors
    • Scientific Advisory Board
    • Business Development
    • Main Investors
    • CONTACT US
  • SCIENCE
    • SNP-Technology
    • Intellectual Property
  • PIPELINE
    • Overview
    • OCS-01 Diabetic macular edema
    • OCS-01 Post Cataract Surgery Inflammation
    • OCS-02 Uveitis
    • OCS-02 Dry Eye
  • NEWS
    • Press releases
  • CAREERS
  • COMPANY

    • ABOUT US
    • Management team
    • Board of Directors
    • Scientific Advisory Board
    • Business Development
    • Main Investors
    • CONTACT US
  • SCIENCE

    • SNP-Technology
    • Intellectual Property
  • PIPELINE

    • Overview
    • OCS-01 Diabetic macular edema
    • OCS-01 Post Cataract Surgery Inflammation
    • OCS-02 Uveitis
    • OCS-02 Dry Eye
  • NEWS

    • Press releases
  • CAREERS
Oculis to Present Recent Progress in its Portfolio at Upcoming Investor Conferences

...

24 November, 2020
Oculis appoints David Jacobs, M.D. as Chief Development Officer
22 October, 2020
Oculis announces presentation of OCS-01 Phase 2 DME study at EURETINA 2020
05 October, 2020
Oculis to present recent milestones at key biotech and ophthalmology conferences
22 September, 2020
Oculis recognized as one of the Top 100 Swiss Startups and ranked in Top 10 Biotech
10 September, 2020
Oculis establishes presence in U.S. and appoints Sylvia Cheung as Chief Financial Officer
01 September, 2020
Oculis to Present at the Upcoming 2020 Summer Private Company Showcase
10 August, 2020
Oculis to Present at the LifeSci Partners Private Company Virtual Summer Symposium
30 July, 2020
Oculis Announces Successful End-of-Phase 2 Meeting with the FDA for OCS-01
27 July, 2020
Oculis to Present at the Upcoming Virtual European Biotech Investor Day 2020
23 June, 2020
Show more
Contact us

Oculis Switzerland
Corporate Headquarters
EPFL Innovation Park Building D
Route J-D. Colladon
1015 Lausanne
Switzerland

+41 21 711 3970

 

Oculis Iceland
Alfheimar 74
6th Floor
104 Reykjavik
Iceland

+354 546 4440

Copyright © 2020 Oculis SA.

    © Oculis – Private policy

    © L’autreagence 2019